• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】13433

【品名】4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde

【CA登记号】123-08-0

【 分 子 式 】C7H6O2

【 分 子 量 】122.12344

【元素组成】C 68.85% H 4.95% O 26.2%

与该中间体有关的原料药合成路线共 38 条

合成路线1

该中间体在本合成路线中的序号:(II)

A new short synthesis of troglitazone has been described: Condensation of the bromoacetal (I) with 4-hydroxybenzaldehyde (II) by means of K2CO3 and NaI in refluxing acetone gives the unsaturated ether (III), which is cyclized with trimethylhydroquinone (IV) by means of bis(trifluoromethylsulfonyl)imide in dichloromethane to yield the 6-hydroxybenzopyran (V). Acylation of (V) with acetic anhydride and DMAP in THF affords the expected acetoxybenzopyran (VI), which is condensed with thiazolidine-2,4-dione (VII) by means of piperidine in toluene to provide the 6-benzylidene-thiazolidine (VIII). The hydrogenation of (VIII) with H2 over Pd/C in methanol gives the corresponding benzyl derivative (IX), which is finally deacetylated with AcOH/HCl/water (3:1:1) in MeOH.

1 Cossy, J.; et al.; A short synthesis of troglitazone: An antidiabetic drug for treating insulin resistance. Bioorg Med Chem Lett 1999, 9, 24, 3439.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 40477 (E)-4-bromo-1-methoxy-3-methyl-2-butenyl methyl ether; (E)-4-bromo-1,1-dimethoxy-3-methyl-2-butene C7H13BrO2 详情 详情
(II) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(III) 40478 4-[[(E)-4,4-dimethoxy-2-methyl-2-butenyl]oxy]benzaldehyde C14H18O4 详情 详情
(IV) 26357 2,3,5-trimethyl-1,4-benzenediol 700-13-0 C9H12O2 详情 详情
(V) 40479 4-[(6-hydroxy-2,5,7,8-tetramethyl-2H-chromen-2-yl)methoxy]benzaldehyde C21H22O4 详情 详情
(VI) 40480 2-[(4-formylphenoxy)methyl]-2,5,7,8-tetramethyl-2H-chromen-6-yl acetate C23H24O5 详情 详情
(VII) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情
(VIII) 40481 2-([4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl)-2,5,7,8-tetramethyl-2H-chromen-6-yl acetate C26H25NO6S 详情 详情
(IX) 40482 2-([4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl)-2,5,7,8-tetramethyl-2H-chromen-6-yl acetate C26H27NO6S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The condensation of 4-hydroxybenzaldehyde (I) with 2-(dimethylamino)ethyl chloride (II) by means of K2CO3 in hot isopropyl ether yields 4-[2-(dimethylamino)ethoxy]benzaldehyde (III), which is treated with hydroxylamine hydrochloride in refluxing ethanol to afford the corresponding oxime (IV). The hydrogenation of (IV) with H2 over RaNi in methanolic ammonia yields 4-[2-(dimethylamino)ethoxy]benzylamine (V), which is finally condensed with 3,4-dimethoxybenzoyl chloride (VI) (obtain303ed from the corresponding acid (VII) with SOCl2) in toluene.

1 Castaner, J.; Mealy, N.; Itopride Hydrochloride. Drugs Fut 1995, 20, 12, 1220.
2 Ogawa, N.; Yasuda, S.; Kato, H.; Sakaguchi, J.; Iwanaga, Y.; Ito, Y.; Nishino, H.; Synthesis, gastrointestinal prokinetic activity and structure-activity relationships of novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives. Chem Pharm Bull 1992, 40, 1, 202-11.
3 Itoh, Y.; Kato, H.; Koshinaka, E.; Ogawa, N.; Nishino, H.; Sakaguchi, J. (Hokuriku Seiyaku Co., Ltd.); Amide cpds., process for preparing the same, and compsn. for activating gastric motor function containing the same. AU 8821862; EP 0306827; JP 1989066153; JP 1989079144; JP 1989085960; JP 1989093568; US 4983633 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 11907 Dimethylaminoethyl chloride; 2-Dimethylaminoethyl chloride; 2-Chloro-N,N-dimethyl-1-ethanamine; N-(2-Chloroethyl)-N,N-dimethylamine 107-99-3 C4H10ClN 详情 详情
(III) 13435 4-[2-(Dimethylamino)ethoxy]benzaldehyde C11H15NO2 详情 详情
(IV) 13436 4-[2-(Dimethylamino)ethoxy]benzaldehyde oxime C11H16N2O2 详情 详情
(V) 13437 2-[4-(Aminomethyl)phenoxy]-N,N-dimethyl-1-ethanamine; N-[2-[4-(Aminomethyl)phenoxy]ethyl]-N,N-dimethylamine C11H18N2O 详情 详情
(VI) 13438 3,4-Dimethoxybenzoyl chloride 3535-37-3 C9H9ClO3 详情 详情
(VII) 13439 3,4-Dimethoxybenzoic acid 93-07-2 C9H10O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

BRL 35135 may be obtained by the following synthetic procedures: Alkylation of 4-hydroxybenzaldehyde (I) with methyl chloroacetate in boiling acetone in the presence of potassium carbonate and a catalytic quantity of potassium iodide gives methyl 4-formylphenoxyacetate (II), which is condensed with nitroethane in glacial acetic acid in the presence of n-butylamine to give the nitrostyrene (III). Reduction of nitrostyrene (III) with steel wool and glacial acetic acid/methanol leads to methyl 4-(2-oxopropyl)phenoxyacetate (IV). Condensation of (IV) with alpha-(aminomethyl-3-chlorobenzenemethanol (VI) and hydrogenation of the resultant imine with platinum in methyl acetate leads to a mixture of diastereomers (VII). Pure BRL 35135 can be obtained from this mixture of diastereomers by fractional crystallization, and subsequent recrystallization, of the hydrobromide salt from methyl acetate-methanol. The ethanolamine (VI) is prepared by addition of trimethylsilyl cyanide to 3-chlorobenzaldehyde (V) in diethyl ether in the presence of a catalytic amount of zinc iodide and subsequent reduction of the trimethylsilylcyanohydrin with lithium aluminum hydride.

1 Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Ethanamine derivs., their preparation and use in pharmaceutical compsns. EP 0023385 .
2 Cantello, B.C.C.; Smith, S.A.; BRL 35135. Drugs Fut 1991, 16, 9, 797.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 13657 methyl 2-(4-formylphenoxy)acetate C10H10O4 详情 详情
(III) 13658 methyl 2-[4-[(E)-2-nitro-1-propenyl]phenoxy]acetate C12H13NO5 详情 详情
(IV) 13659 methyl 2-[4-(2-oxopropyl)phenoxy]acetate C12H14O4 详情 详情
(V) 13660 3-Chlorobenzaldehyde 587-04-2 C7H5ClO 详情 详情
(VI) 13661 2-Amino-1-(3-chlorophenyl)-1-ethanol 121652-86-6 C8H10ClNO 详情 详情
(VII) 13662 methyl 2-[4-(2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl)phenoxy]acetate C20H24ClNO4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(V)

Condensation of 2'-fluoroacetophenone (I) with 4-methoxybenzaldehyde (II) under acidic conditions afforded chalcone (III). This was subsequently demethylated with boron tribromide to yield the 4-hydroxy chalcone (IV). Alternatively, chalcone (IV) was also obtained by condensation of 2'-fluoroacetophenone (I) with 4-hydroxybenzaldehyde (V). Reaction of chalcone (IV) with 2-(dimethylamino)ethoxyamine dihydrochloride (VI) produced the corresponding oxime as a mixture of syn target compound and anti (VIII) isomers. The title syn isomer was isolated by fractional extraction at increasing pH values or, alternatively, by recrystallization as the corresponding hemifumarate salt. Optionally, the undesired anti compound (VIII) was isomerized by acidic treatment to produce a 45:55 mixture of target compound and (VIII).

1 Congy, C.; Labeeuw, B.; Gueule, P.; Rinaldi, M. (Sanofi-Synthelabo); Propenone oxime ethers, method for their preparation and pharmaceutical compsns. containing them. EP 0373998; FR 2639942; JP 1990262552 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48065 1-(2-fluorophenyl)-1-ethanone 445-27-2 C8H7FO 详情 详情
(II) 27251 4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde 123-11-5 C8H8O2 详情 详情
(III) 48066 (E)-1-(2-fluorophenyl)-3-(4-methoxyphenyl)-2-propen-1-one C16H13FO2 详情 详情
(IV) 48067 (E)-1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one C15H11FO2 详情 详情
(V) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VI) 48068 2-(aminooxy)-N,N-dimethyl-1-ethanamine; N-[2-(aminooxy)ethyl]-N,N-dimethylamine C4H12N2O 详情 详情
(VIII) 48069 (E)-1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one O-[2-(dimethylamino)ethyl]oxime C19H21FN2O2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

Two new related syntheses of pioglitazone hydrochloride have been described: 1) The condensation of 2-(5-ethylpyridin-2-yl)ethanol (I) with 4-hydroxybenzaldehyde (II) by means of benzyltributylammonium chloride, NaOH and tosyl chloride gives 4-[2-(5-ethylpyridin-2-yl)ethoxy]benzaldehyde (III), which is condensed with thiazolidine-2,4-dione (IV) in basic medium to afford 5-[-4-[2-(5-ethylpyridin-2-yl)ethoxy]benzylidene]thiazolidine-2,4-dione (V). Finally, this compound is hydrogenated in the usual way. 2) The condensation of alcohol (I) with 4-fluorobenzonitrile (VI) by means of NaH gives 4-[2-(5-ethylpyridin-2-yl)ethoxy]benzonitrile (VII), which is reduced with Raney Nickel and formic acid to the aldehyde (III), already obtained.

1 Momose, Y.; Sohda, T.; Meguro, K.; Hatanaka, C.; Ikeda, H.; Oi, S.; Studies on antidiabetic agents: Synthesis and biological activities of pioglitazone and related compounds. 11th Symp Med Chem (Dec 4-5, Tokushima) 1990, Abst P-11.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14139 2-(5-Ethyl-2-pyridinyl)-1-ethanol 5223-06-3 C9H13NO 详情 详情
(II) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(III) 14141 4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzaldehyde C16H17NO2 详情 详情
(IV) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情
(V) 14143 5-((E)-[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methylidene)-1,3-thiazolane-2,4-dione 144809-28-9 C19H18N2O3S 详情 详情
(VI) 14144 4-Fluorobenzonitrile 1194-02-1 C7H4FN 详情 详情
(VII) 14145 4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzonitrile C16H16N2O 详情 详情

合成路线6

该中间体在本合成路线中的序号:(IV)

This compound has been obtained by several different methods. The reaction of 2-(5-ethyl-2-pyridyl)ethanol (I) with Ts-Cl and NaOH in THF gives the corresponding tosylate (II), which is condensed with 4-hydroxybenzaldehyde (IV) by means of BnNBu3Cl and NaOH or K2CO3 to yield the aryl ether (V) (1-3). The condensation of (V) with thiazolidine-2,4-dione (VI) in refluxing ethanol affords the 5-benzylidenethiazolidinedione (VII), which is finally reduced with H2 over Pd/C in DMF or dioxane. The reaction of 2-(5-ethyl-2-pyridyl)ethanol (I) with Ms-Cl and TEA in dichloromethane THF gives the corresponding mesylate (III), which is condensed with 4-hydroxybenzaldehyde (IV) by means of K2CO3 to yield the already reported aryl ether (V). The condensation of 2-(5-ethyl-2-pyridyl)ethanol (I) with 4-fluorobenzonitrile (VIII) by means of NaH gives 4-[2-(5-ethyl-2-pyridyl)ethoxy]benzonitrile (IX), which is reduced with RaNi and HCOOH to yield the already reported 4-ethoxybenzaldehyde derivative (V).

1 Saito, Y.; Yamashita, M.; Mizufune, H. (Takeda Chemical Industries, Ltd.); Process for preparing 4-(2-(2-pyridyl)ethoxy)benzaldehyde derivs.. EP 0816340 .
2 Mizuno, Y.; Arita, M. (Takeda Chemical Industries, Ltd.); Method for producing ethers. EP 0506273 .
3 Meguro, K.; Momose, Y.; Sohda, T.; Oi, S.; Ikeda, H.; Hatanaka, C.; Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds. Chem Pharm Bull 1991, 39, 6, 1440-5.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14139 2-(5-Ethyl-2-pyridinyl)-1-ethanol 5223-06-3 C9H13NO 详情 详情
(II) 62865 2-(5-ethyl-2-pyridinyl)ethyl 4-methylbenzenesulfonate C16H19NO3S 详情 详情
(III) 62866 2-(5-ethyl-2-pyridinyl)ethyl methanesulfonate C10H15NO3S 详情 详情
(IV) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(V) 14141 4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzaldehyde C16H17NO2 详情 详情
(VI) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情
(VII) 14143 5-((E)-[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methylidene)-1,3-thiazolane-2,4-dione 144809-28-9 C19H18N2O3S 详情 详情
(VIII) 14144 4-Fluorobenzonitrile 1194-02-1 C7H4FN 详情 详情
(IX) 14145 4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzonitrile C16H16N2O 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XII)

3) The reaction of 4-hydroxybenzaldehyde (XII) with benzyl bromide and K2CO3 in acetone gives 4-(benzyloxy)benzaldehyde (XIII), which is condensed with 4-fluoroaniline (XIV) in isopropanol, yielding the imine (II). Cyclization of (II) with methyl 4-(chloroformyl)butyrate (XV) by means of tributylamine in toluene affords the trans-azetidinone (XVI), which is hydrolyzed with LiOH in THF/water to provide the propionic acid derivative (XVII). The reaction of (XVII) with oxalyl chloride in dichloromethane gives the corresponding acyl chloride (XVIII), which is condensed with 4-fluorophenylmagnesium bromide (XIX) by means of ZnCl2 and Pd(PPh3)4 in THF to yield a racemic mixture of saturated trans-azetidinones that was resolved by chiral HPLC to the trans-(3R,4S)-enantiomer (XX). The enantioselective reduction of (XX) with BH3 and the chiral oxaborole catalyst CBS gives the benzylated alcohol (XI), which is finally debenzylated as before with H2 over Pd/C in ethanol.

1 Vaccaro, W.D.; Sher, R.; Davis, H.R. Jr.; 2-Azetidinone cholesterol absorption inhibitors: Increased potency by substitution of the C-4 phenyl ring. Bioorg Med Chem 1998, 6, 9, 1429.
2 Rosenblum, S.B.; Dugar, S.; Burnett, D.A.; Clader, J.W.; McKittrick, B.A. (Schering Corp.); Hydroxy-substd. azetidinone cpds. useful as hypocholesterolemic agents. EP 0720599; JP 1996509989; US 5631365; WO 9508532 .
3 Castañer, R.M.; Sorbera, L.A.; Castañer, J.; Ezetimibe. Drugs Fut 2000, 25, 7, 679.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
trans-(XVI) 20652 (rac)-methyl 3-[(2S*,3R*)-2-[4-(benzyloxy)phenyl]-1-(4-fluorophenyl)-4-oxoazetidinyl]propanoate C26H24FNO4 详情 详情
trans-(XVII) 20653 3-[(2S,3R)-2-[4-(benzyloxy)phenyl]-1-(4-fluorophenyl)-4-oxoazetidinyl]propionic acid C25H22FNO4 详情 详情
trans-(XVIII) 20654 3-[(2S,3R)-2-[4-(benzyloxy)phenyl]-1-(4-fluorophenyl)-4-oxoazetidinyl]propanoyl chloride C25H21ClFNO3 详情 详情
(II) 37689 N-[(Z)-[4-(benzyloxy)phenyl]methylidene]-4-fluoroaniline; N-[(Z)-[4-(benzyloxy)phenyl]methylidene]-N-(4-fluorophenyl)amine C20H16FNO 详情 详情
(XI) 20657 (3R,4S)-4-[4-(benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-2-azetidinone C31H27F2NO3 详情 详情
(XII) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(XIII) 29179 4-(Benzyloxy)benzaldehyde 4397-53-9 C14H12O2 详情 详情
(XIV) 37690 4-fluorophenylamine; 4-fluoroaniline 371-40-4 C6H6FN 详情 详情
(XV) 20650 methyl 5-chloro-5-oxopentanoate; methyl-4-chloroformylbutyrate 1501-26-4 C6H9ClO3 详情 详情
(XIX) 13643 4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide 352-13-6 C6H4BrFMg 详情 详情
(XX) 20656 (3R,4S)-4-[4-(benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-2-azetidinone C31H25F2NO3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(V)

The enantioselective reduction of the oxazolidinone (I) with BH3/SMe2 and a chiral borinated catalyst gives the (S)-alcohol (II), which is condensed with the labeled imine (III) (prepared by reaction of 4-fluoroaniline (IV) and 13C-labeled 4-hydroxybenzaldehyde (V)) by means of TiCl4 in dichloromethane to yield the silylated adduct (VI) (previously the reactants are silylated with Tms-Cl and DIEA). Finally, adduct (VI) is resilylated with bis(trimethylsilyl)acetamide and cyclized and desilylated by treatment with TBAF in dichloromethane to afford the target 13C-labeled SCH-58235.

1 Hesk, D.; et al.; Synthesis of 3H, 14C and 13C6 labelled Sch 58235. J Label Compd Radiopharm 2002, 45, 2, 145.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 53476 1-(4-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,5-pentanedione n/a C20H18FNO4 详情 详情
(II) 53477 (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one n/a C20H20FNO4 详情 详情
(III) 53478   n/a C13H10FNO 详情 详情
(III) 53481 4-{[(4-fluorophenyl)imino]methyl}phenol 3382-63-6 C13H10FNO 详情 详情
(IV) 37690 4-fluorophenylamine; 4-fluoroaniline 371-40-4 C6H6FN 详情 详情
(V) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(V) 53479   n/a C7H6O2 详情 详情
(VI) 16734 (2S)-1-(tert-butoxycarbonyl)tetrahydro-1H-pyrrole-2-carboxylic acid; N-alpha-t-BOC-L-proline; (2S)-1-(tert-butoxycarbonyl)-2-pyrrolidinecarboxylic acid C10H17NO4 详情 详情
(VI) 53480   n/a C37H40F2N2O7SSi 详情 详情

合成路线9

该中间体在本合成路线中的序号:(V)

The enantioselective reduction of the oxazolidinone (I) with BH3/SMe2 and a chiral borinated catalyst gives the (S)-alcohol (II), which is condensed with the labeled imine (III) (prepared by reaction of 4-fluoroaniline (IV) and 14C-labeled 4-hydroxybenzaldehyde (V)) by means of TiCl4 in dichloromethane to yield the silylated adduct (VI) (previously the reactants are silylated with Tms-Cl and DIEA). Finally, adduct (VI) is resilylated with bis(trimethylsilyl)acetamide and cyclized and desilylated by treatment with TBAF in dichloromethane to afford the target 14C-labeled SCH-58235.

1 Hesk, D.; et al.; Synthesis of 3H, 14C and 13C6 labelled Sch 58235. J Label Compd Radiopharm 2002, 45, 2, 145.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 53476 1-(4-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,5-pentanedione n/a C20H18FNO4 详情 详情
(II) 53477 (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one n/a C20H20FNO4 详情 详情
(III) 53481 4-{[(4-fluorophenyl)imino]methyl}phenol 3382-63-6 C13H10FNO 详情 详情
(III) 53484   n/a C13H10FNO 详情 详情
(IV) 37690 4-fluorophenylamine; 4-fluoroaniline 371-40-4 C6H6FN 详情 详情
(V) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(V) 53483 4-hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VI) 53482 (1S,4R,5S)-5-(4-fluoroanilino)-1-(4-fluorophenyl)-4-{[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]carbonyl}-5-{4-[(trimethylsilyl)oxy]phenyl}pentyl methanesulfonate n/a C37H40F2N2O7SSi 详情 详情
(VI) 53485   n/a C37H40F2N2O7SSi 详情 详情

合成路线10

该中间体在本合成路线中的序号:(VI)

Acetylation of N-benzoylaspartic acid beta-methyl ester (I) with acetic anhydride and subsequent decarboxylation gave the 3-benzoylamino-4-oxovalerate (II). The methyl oxazolylacetate (III) was prepared by cyclization of 4-oxovalerate (II) in the presence of Ac2O. Ester (III) was then reduced to alcohol (IV) with LiBH4 and further converted to mesylate (V) with methanesulfonyl chloride and Et3N. Coupling between mesylate (V) and 4-hydroxybenzaldehyde (VI) gave ether (VII). Knoevenagel condensation of (VII) with dimethyl malonate using piperidine acetate produced the benzylidene malonate (VIII). Finally, catalytic hydrogenation with Pd/C furnished JTP-20993. The title compound (JTT-501) is obtained by reaction of JTP-20993 with NH2OH.

1 Shinkai, H.; The isoxazolidine-3,5-dione hypoglycemic agent JTT-501 and other nonthiazolidinedione insulin sensitizers. Drugs Fut 1999, 24, 8, 893.
2 Shinkai, H. (Japan Tobacco Inc.); Isoxazolidinedione deriv. and use thereof. EP 0684242; JP 1996517913; US 5728720; US 6057343; WO 9518125 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
JTP-20993 41516 dimethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl]malonate C24H25NO6 详情 详情
(I) 41311 2-(benzoylamino)-4-methoxy-4-oxobutyric acid C12H13NO5 详情 详情
(II) 41312 methyl 3-(benzoylamino)-4-oxopentanoate C13H15NO4 详情 详情
(III) 41313 methyl 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetate C13H13NO3 详情 详情
(IV) 19874 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol C12H13NO2 详情 详情
(V) 41315 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl methanesulfonate C13H15NO4S 详情 详情
(VI) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VII) 19372 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzaldehyde C19H17NO3 详情 详情
(VIII) 19374 dimethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzylidene]malonate C24H23NO6 详情 详情

合成路线11

该中间体在本合成路线中的序号:(VI)

Friedel-Crafts reaction between 4-hydroxyphenylacetic acid (I) and resorcinol (II) by means of BF3.Et2O provides trihydroxydeoxy benzoin (III), which is then protected with dihydropyran (IV) in the presence of TsOH to give the bis-THP ether (V). Knoevenagel reaction of (V) with 4-hydroxybenzaldehyde (VI) in the presence of piperidine in refluxing benzene, followed by alkylation with 1-(2-chloroethyl)piperidine (VII) in the presence of Cs2CO3 in refluxing acetone:H2O to yield chromanone (VIII). Alternatively, (VIII) can be synthesized by reaction of (V) with compound (IX) (obtained in turn from reaction between aldehyde (VI) and chloro derivative (VII) with K2CO3 in DMF) by means of piperidine in refluxing toluene, followed by treatment with NaOAc in refluxing MeOH. Chromanone (VIII) is then alkylated either with MeLi or with methylmagnesium bromide in THF and then dehydrated and deprotected in HOAc furnishing chromene (X). Racemic compound (X) is then resolved to afford enantiomer (XI) either by preparative chiral HPLC or by chemical resolution of the corresponding diastereomeric salt obtained by reaction with (+)-CSA in DMF/CH2Cl2, and treatment of the resulting salt with saturated K2CO3 . Finally, the target product is obtained by acylation of (XI) by reaction with pivaloyl chloride (XII) and Et3N in CH2Cl2.

1 Caron, B.; Cloutier, J.; Gauthier, S.; (S)-(+)-4-[7-(2, 2-Dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H-1-benzopyran-3-yl]phenyl 2, 2-dimethylpropanoate (EM-800): A highly potent, specific, and orally active nonsteroidal antiestrogen. J Med Chem 1997, 40, 14, 2117.
2 Labrie, F.; Merand, Y.; Gauthier, S. (Endorecherche Inc.); Benzopyran-containing cpds. and method for their use. EP 0811006; EP 1167364; JP 1999500133; WO 9626201 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18430 2-(4-Hydroxyphenyl)acetic acid; 4-Hydroxyphenylacetic acid 156-38-7 C8H8O3 详情 详情
(II) 10361 1,3-Dihydroxybenzene; m-Dihydroxybenzene; Resorcinol; Resorcin; 1,3-Benzenediol 108-46-3 C6H6O2 详情 详情
(III) 51229 1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)-1-ethanone C14H12O4 详情 详情
(IV) 13684 3,4-Dihydro-2H-pyran;2,3-Dihydro-4H-pyran; 5,6-Dihydro-4H-pyran;Dihydropyran 110-87-2 C5H8O 详情 详情
(V) 51230 1-[2-hydroxy-4-(tetrahydro-2H-pyran-2-yloxy)phenyl]-2-[4-(tetrahydro-2H-pyran-2-yloxy)phenyl]-1-ethanone C24H28O6 详情 详情
(VI) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VII) 10117 1-(2-Chloroethyl)piperidine; N-(2-Chloroethyl)piperidine 1932-03-2 C7H14ClN 详情 详情
(VIII) 51231 2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-7-(tetrahydro-2H-pyran-2-yloxy)-3-[4-(tetrahydro-2H-pyran-2-yloxy)phenyl]-2,3-dihydro-4H-chromen-4-one C38H45NO7 详情 详情
(IX) 35795 4-[2-(1-piperidinyl)ethoxy]benzaldehyde 26815-04-3 C14H19NO2 详情 详情
(X) 51232 3-(4-hydroxyphenyl)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H-chromen-7-ol C29H31NO4 详情 详情
(XI) 51233 (2S)-3-(4-hydroxyphenyl)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H-chromen-7-ol C29H31NO4 详情 详情
(XII) 13597 2,2-Dimethylpropanoyl chloride; Pivaloyl chloride 3282-30-2 C5H9ClO 详情 详情

合成路线12

该中间体在本合成路线中的序号:(I)

4-Hydroxybenzaldehyde (I) was alkylated with 2,2,3,3-tetrafluoropropyl tosylate (A) to give ether (II). Subsequent Horner-Emmons condensation of (II) with triethyl phosphonocrotonate (III) provided dienoate (IV), that was further reduced to alcohol (V) by means of DIBAL. Oxidation of (V) with activated MnO2 then gave aldehyde (VI).

1 Tajima, Y.; Oida, S.; Konosu, T.; et al.; Synthesis and antifungal activities of R-102557 and related dioxane-triazole derivatives. Chem Pharm Bull 2000, 48, 5, 694.
2 Oida, S.; Tanaka, T.; Tajima, Y.; Konosu, T.; Somada, A.; Miyaoka, T.; Yasuda, H. (Sankyo Co., Ltd.); Triazole antifungal agent. EP 0841327; JP 1996333350; US 5977152; WO 9631491 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 41331 2,2,3,3-tetrafluoropropyl 4-methylbenzenesulfonate C10H10F4O3S 详情 详情
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 15481 4-(2,2,3,3-tetrafluoropropoxy)benzaldehyde C10H8F4O2 详情 详情
(III) 27705 methyl 4-amino-2-(1-naphthyl)benzoate C18H15NO2 详情 详情
(IV) 41332 ethyl (2E,4E)-5-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-pentadienoate C16H16F4O3 详情 详情
(V) 41333 (2E,4E)-5-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-pentadien-1-ol C14H14F4O2 详情 详情
(VI) 41334 (2E,4E)-5-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-pentadienal C14H12F4O2 详情 详情

合成路线13

该中间体在本合成路线中的序号:(IV)

By condensation of 4-(2-quinolinylmethoxy)benzaldeyde (I) with 2-hydroxy-5(1H-tetrazol-5-yl)acetophenone (II) by means of KOH in ethanol/water. The intermediates (I) and (II) have been obtained as follows: Benzaldehyde (I): By condensation of 2-(chloromethyl)quinoline (III) with 4-hydroxybenzaldehyde (IV) by means of K2CO3 in hot DMF. Acetophenone (II): The acetylation of 4-hydroxybenzonitrile (V) with acetic anhydride/sulfuric acid and AlCl3 gives 5-cyano-2-hydroxyacetophenone (VI), which is then cyclized with sodium azide and ammonium chloride in hot DMF.

1 Zwaagstra, M.E.; et al.; Synthesis and structure - activity relationships of carboxylated chalcones: A novel series of CysLT1 (LTD4) receptor antagonists. J Med Chem 1997, 40, 7, 1075.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25883 4-(2-quinolinylmethoxy)benzaldehyde C17H13NO2 详情 详情
(II) 25884 1-[2-hydroxy-5-(1H-1,2,3,4-tetraazol-5-yl)phenyl]-1-ethanone C9H8N4O2 详情 详情
(III) 13162 2-(Chloromethyl)quinoline; alpha-Chloroquinaldine 4377-41-7 C10H8ClN 详情 详情
(IV) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(V) 25109 4-hydroxybenzonitrile 767-00-0 C7H5NO 详情 详情
(VI) 12857 3-Acetyl-4-hydroxybenzonitrile C9H7NO2 详情 详情

合成路线14

该中间体在本合成路线中的序号:(I)

Alkylation of 4-hydroxybenzaldehyde (I) with chloro derivative (II) by means of K2CO3 in DMF at reflux affords benzaldehyde derivative (III), which is reduced with NaBH4 in MeOH to provide the benzylic alcohol (IV) --alternatively, alcohol (IV) can be obtained by reaction of 4-hydroxybenzyl alcohol (V) with chloro derivative (II) by means of NaOH and benzyltriethylammonium bromide in toluene--. Alcohol (V) is treated with HCl in THF and then chlorinated with SOCl2 to furnish hydrochloride salt (VI), which is condensed with the indole derivative (VII) – produced by condensation of the bromo ketone (VIII) and 4-benzyloxyaniline hydrochloride (IX) either refluxing by with DMF or with Et3N in refluxing DMF – by means of NaH in DMF to give the N-alkylated indole (X). Finally, the O-benzyl protecting groups of (X) are removed by transfer hydrogenolysis using cyclohexadiene and Pd/C.

1 Miller, C.P.; Collini, M.D.; Tran, B.D.; et al.; Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens. J Med Chem 2001, 44, 11, 1654.
2 Vid, G.; Potoski, J.R.; Raveendranath, P.; Zeldis, J.; Ren, J. (American Home Products Corp.); Novel aryloxy-alkyl-dialkylamines. EP 1025077; WO 9919293 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 22918 1-(2-chloroethyl)azepane C8H16ClN 详情 详情
(III) 60165 4-[2-(1-azepanyl)ethoxy]benzaldehyde C15H21NO2 详情 详情
(IV) 60166 {4-[2-(1-azepanyl)ethoxy]phenyl}methanol C15H23NO2 详情 详情
(V) 29474 4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol 4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol 623-05-2 C7H8O2 详情 详情
(VI) 60167 1-{2-[4-(chloromethyl)phenoxy]ethyl}azepane; 2-(1-azepanyl)ethyl 4-(chloromethyl)phenyl ether C15H22ClNO 详情 详情
(VII) 38490 5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole; benzyl 4-[5-(benzyloxy)-3-methyl-1H-indol-2-yl]phenyl ether C29H25NO2 详情 详情
(VIII) 38489 4-Benzyloxy-alpha-bromopropiophenone; 1-[4-(benzyloxy)phenyl]-2-bromo-1-propanone; alpha-Bromo-4-benzyloxy propiophenone 54081-45-9 C16H15BrO2 详情 详情
(IX) 22460 4-(benzyloxy)aniline; 4-(benzyloxy)phenylamine C13H13NO 详情 详情
(X) 38495 1-[4-[2-(1-azepanyl)ethoxy]benzyl]-5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole; 4-[1-[4-[2-(1-azepanyl)ethoxy]benzyl]-5-(benzyloxy)-3-methyl-1H-indol-2-yl]phenyl benzyl ether C44H46N2O3 详情 详情

合成路线15

该中间体在本合成路线中的序号:(III)

The reaction of 2-(4-hydroxyphenyl)ethyl alcohol (I) with Ms-Cl and TEA in dichloromethane gives the bis-methanesulfonate (II), which is condensed with 4-hydroxybenzaldehyde (III) by means of K2CO3 in acetonitrile to yield the substituted benzaldehyde (IV). The condensation of (IV) with phosphonium salt (V) by means of tetramethylguanidine (TMG) in chloroform affords the acrylic ester (VI), which is reduced with H2 over Pd/C in ethyl acetate to provide the propionic ester (VII). The hydrolysis of (VII) with LiOH in THF/water gives the propionic acid (VIII) as a racemic mixture, which is condensed with (R)-phenylglycinol (IX) by means of EDC, HOBt and DIEA in dichloromethane to yield the amide (X) as a diastereomeric mixture that is separated by crystallization and chromatography. The desired (S)-isomer (XI) is treated with H2SO4 in hot dioxane/water to furnish the target propionic acid.

1 McIntyre, J.A.; Castaner, J.; Bayes, M.; Tesaglitazar. Drugs Fut 2003, 28, 10, 959.
2 Andersson, K.; Boije, M.; Inghardt, T.; Lindstedt Alstermark, E.-L.; Gottfries, J.; Li, L. (AstraZeneca plc); New 3-aryl-2-aryl propionic acid derivs. and analogs. EP 1084101; EP 1084102; EP 1084103; WO 9962870; WO 9962871; WO 9962872 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 47355 4-(2-hydroxyethyl)phenol 501-94-0 C8H10O2 详情 详情
(II) 50403 4-[2-[(methylsulfonyl)oxy]ethyl]phenyl methanesulfonate C10H14O6S2 详情 详情
(III) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(IV) 50404 4-[2-(4-formylphenoxy)ethyl]phenyl methanesulfonate C16H16O5S 详情 详情
(V) 50405 (Ethoxy(ethoxycarbonyl)methyl)triphenylphosphonium chloride C24H26ClO3P 详情 详情
(VI) 50406 ethyl (E)-2-ethoxy-3-[4-([4-[(methylsulfonyl)oxy]phenethyl]oxy)phenyl]-2-propenoate C22H26O7S 详情 详情
(VII) 50407 ethyl 2-ethoxy-3-[4-([4-[(methylsulfonyl)oxy]phenethyl]oxy)phenyl]propanoate C22H28O7S 详情 详情
(VIII) 50408 2-ethoxy-3-[4-([4-[(methylsulfonyl)oxy]phenethyl]oxy)phenyl]propionic acid C20H24O7S 详情 详情
(IX) 14376 (2R)-2-amino-2-phenyl-1-ethanol; (R)-(-)-2-phenylglycinol; (R)-2-amino-2-phenyl-1-ethanol 56613-80-0 C8H11NO 详情 详情
(X) 50409 4-[2-[4-(2-ethoxy-3-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-oxopropyl)phenoxy]ethyl]phenyl methanesulfonate C28H33NO7S 详情 详情
(XI) 50410 4-[2-[4-((2S)-2-ethoxy-3-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-oxopropyl)phenoxy]ethyl]phenyl methanesulfonate C28H33NO7S 详情 详情

合成路线16

该中间体在本合成路线中的序号:(VI)

Treatment of chromane (I) with metanesulfonyl chloride in pyridine at 0 C afforded mesylate (II), which was treated with 2-methylaminoethanol (III) to afford tertiary amine (IV). Reaction with SOCl2 gave chloride (V), and further reaction with p-hydroxybenzaldehyde (VI) provided (VII). Aldehyde (VII) was then condensed with 2,4-thiazolidinedione (VIII) in the presence of piperidine benzoate in toluene to furnish (IX). Finally, the benzyl protecting group was removed by treatment with acetic acid-hydrochloric acid at 60 C to give the title compound.

1 Reddy, K.A.; Lohray, B.B.; Bhushan, V.; Reddy, A.S.; Kishore, P.H.; Rao, VV.; Saibaba, V.; Bajji, A.C.; Rajesh, B.M.; Reddy, K.V.; Chakrabarti, R.; Rajagopalan, R.; Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif. Bioorg Med Chem Lett 1998, 8, 9, 999-1002.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18084 [6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methanol C21H26O3 详情 详情
(II) 18085 [6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl methanesulfonate C22H28O5S 详情 详情
(III) 13324 2-Methylaminoethanol; 2-(Methylamino)-1-ethanol 109-83-1 C3H9NO 详情 详情
(IV) 18086 2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]-1-ethanol C24H33NO3 详情 详情
(V) 18087 N-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]-N-(2-chloroethyl)-N-methylamine; N-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]-2-chloro-N-methyl-1-ethanamine C24H32ClNO2 详情 详情
(VI) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VII) 18088 4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]benzaldehyde C31H37NO4 详情 详情
(VIII) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情
(IX) 18089 5-[(Z)-(4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]phenyl)methylidene]-1,3-thiazolidine-2,4-dione C34H38N2O5S 详情 详情

合成路线17

该中间体在本合成路线中的序号:(IX)

3,5-Di-tert-butyl-4-hydroxybenzoic acid (I) was converted to amide (III) via activation as the acyl imidazole (II) followed by treatment with aqueous ammonia. Subsequent condensation of (III) with ethyl 4-chloroacetoacetate (IV) produced oxazole (V). Basic hydrolysis of the ethyl ester of (V) yielded carboxylic acid (VI), which was reduced to alcohol (VII) with borane in THF. Treatment of (VII) with methanesulfonyl chloride and triethylamine generated mesylate (VIII). This was coupled with 4-hydroxybenzaldehyde (IX), yielding ether (X). Finally, reductive condensation of (X) with ethyl methylamine in the presence of NaBH3CN furnished the corresponding tertiary amine.

1 Heinz, L.J.; Panetta, J.A.; Phillips, M.L.; Shadle, J.K. (Eli Lilly and Company); Novel cpds. useful as neuro-protective agents. EP 0971709; WO 9815274 .
2 Shannon, H.E.; Panetta, J.A. (Eli Lilly and Company); Method for treating pain. WO 9909980 .
3 Shannon, H.E.; Panetta, J.A. (Eli Lilly and Company); Method for treating neuropathic pain. WO 9909979 .
4 Heinz, L.J.; Panetta, J.A.; Phillips, M.L.; Rieck, J.A.; Rizzo, J.R.; Shadle, J.K.; Varie, D.L.; Anderson, B.A. (Eli Lilly and Company); Oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents. EP 0908454; WO 9918091 .
5 Panetta, J.A.; Shannon, H.E. (Eli Lilly and Company); Method for treating pain. WO 9909829 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
40588 N-methyl-1-ethanamine; N-ethyl-N-methylamine 624-78-2 C3H9N 详情 详情
(I) 19980 3,5-di(tert-butyl)-4-hydroxybenzoic acid 1421-49-4 C15H22O3 详情 详情
(II) 35204 [3,5-di(tert-butyl)-4-hydroxyphenyl](1H-imidazol-1-yl)methanone C18H24N2O2 详情 详情
(III) 35205 3,5-di(tert-butyl)-4-hydroxybenzamide C15H23NO2 详情 详情
(IV) 23541 ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate 638-07-3 C6H9ClO3 详情 详情
(V) 35206 ethyl 2-[2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-oxazol-4-yl]acetate C21H29NO4 详情 详情
(VI) 35207 2-[2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-oxazol-4-yl]acetic acid C19H25NO4 详情 详情
(VII) 35208 2,6-di(tert-butyl)-4-[4-(2-hydroxyethyl)-1,3-oxazol-2-yl]phenol C19H27NO3 详情 详情
(VIII) 35209 2-[2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-oxazol-4-yl]ethyl methanesulfonate C20H29NO5S 详情 详情
(IX) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(X) 35210 4-(2-[2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-oxazol-4-yl]ethoxy)benzaldehyde C26H31NO4 详情 详情

合成路线18

该中间体在本合成路线中的序号:(V)

The target compound was obtained by several related ways. Indolylethanol (III) was either prepared by alkylation of indole (I) with methyl bromoacetate, followed by reduction of the resulting indolylacetate (II) with LiAlH4 or by alkylation of (I) with 2-bromoethanol. Alkylation of (III) with 4-fluorobenzaldehyde (IV) in the presence of NaH or condensation with 4-hydroxybenzaldehyde (V) under Mitsunobu conditions provided ether (VII). Alternatively, (VII) was prepared by alkylation of indole (I) with 4-(bromoethoxy)benzaldehyde (VI). Then, Knoevenagel condensation of aldehyde (VII) with 2,4-thiazolidinedione (VIII) in the presence of piperidinium benzoate in refluxing toluene with azeotropic removal of water yielded benzylidene compound (IX). Reduction of the olefinic double bond by either hydrogenation in the presence of an excess of Pd/C or by chemical reduction with Mg in MeOH provided the target benzyl compound. Alternatively, indolylethanol (III) was condensed with hydroxybenzyl compound (X) in the presence of tributyl phosphine and 1,1'-(azodicarbonyl)dipiperidine (ADDP) in benzene to give (XI), which was finally deprotected by hydrogenation in the presence of an excess of Pd/C in dioxan.

1 Lohray, B.B.; et al.; Novel indole containing thiazolidinedione derivatives as potent euglycemic and hypolipidaemic agents. Bioorg Med Chem Lett 1997, 7, 7, 785.
2 Rao, K.N.; Reddy, A.K.; Reddy, P.G.; Vikramadityan, R.K.; Madhavan, G.R.; Bhushan, V.; Rajagopolan, R.; Mamidi, R.N.V.S.; Rajesh, B.M.; Jajoo, H.K.; Rao, B.P.; Murali, N.; Chakrabarti, R.; Subramaniam, S.; Lohray, B.B.; Novel euglycemic and hypolipidemic agent. J Med Chem 1998, 41, 10, 1619.
3 Fujita, T.; Fujimoto, K.; Yoshioka, T.; Yanagisawa, H.; Fujiwara, T.; Horikoshi, H.; Oguchi, M.; Wada, K. (Sankyo Co., Ltd.); Heterocyclic cpds. having antidiabetic activity, their preparation and their use. CA 2146701; EP 0676398; JP 1995330728; US 5624935; US 5834501; US 5962470; US 6117893 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15292 Indole; 1H-indole 120-72-9 C8H7N 详情 详情
(II) 18795 methyl 2-(1H-indol-1-yl)acetate C11H11NO2 详情 详情
(III) 18796 2-(1H-indol-1-yl)-1-ethanol C10H11NO 详情 详情
(IV) 12337 4-fluorobenzaldehyde 459-57-4 C7H5FO 详情 详情
(V) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VI) 18799 4-(2-bromoethoxy)benzaldehyde 52191-15-8 C9H9BrO2 详情 详情
(VII) 18800 4-[2-(1H-indol-1-yl)ethoxy]benzaldehyde C17H15NO2 详情 详情
(VIII) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情
(IX) 18802 5-((E)-[4-[2-(1H-indol-1-yl)ethoxy]phenyl]methylidene)-1,3-thiazolidine-2,4-dione C20H16N2O3S 详情 详情
(X) 18803 5-(4-hydroxybenzyl)-3-trityl-1,3-thiazolidine-2,4-dione C29H23NO3S 详情 详情
(XI) 18804 5-[4-[2-(1H-indol-1-yl)ethoxy]benzyl]-3-trityl-1,3-thiazolidine-2,4-dione C39H32N2O3S 详情 详情

合成路线19

该中间体在本合成路线中的序号:(VI)

Acetylation of N-benzoylaspartic acid beta-methyl ester (I) with acetic anhydride and subsequent decarboxylation gave the 3-benzoylamino-4-oxovalerate (II). The methyl oxazolylacetate (III) was prepared by cyclization of 4-oxovalerate (II) in the presence of Ac2O. Ester (III) was then reduced to alcohol (IV) with LiBH4 and further converted to mesylate (V) with methanesulfonyl chloride and Et3N. Coupling between mesylate (V) and 4-hydroxybenzaldehyde (VI) gave ether (VII). Knoevenagel condensation of (VII) with dimethyl malonate using piperidine acetate produced the benzylidene malonate (VIII). Finally, catalytic hydrogenation with Pd/C furnished the title compound.

1 Shinkai, H.; et al.; Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents. J Med Chem 1998, 41, 11, 1927.
2 Shinkai, H.; The isoxazolidine-3,5-dione hypoglycemic agent JTT-501 and other nonthiazolidinedione insulin sensitizers. Drugs Fut 1999, 24, 8, 893.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 41311 2-(benzoylamino)-4-methoxy-4-oxobutyric acid C12H13NO5 详情 详情
(II) 41312 methyl 3-(benzoylamino)-4-oxopentanoate C13H15NO4 详情 详情
(III) 41313 methyl 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetate C13H13NO3 详情 详情
(IV) 19874 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol C12H13NO2 详情 详情
(V) 41315 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl methanesulfonate C13H15NO4S 详情 详情
(VI) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VII) 19372 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzaldehyde C19H17NO3 详情 详情
(VIII) 19374 dimethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzylidene]malonate C24H23NO6 详情 详情

合成路线20

该中间体在本合成路线中的序号:(I)

The reaction of 4-hydroxybenzaldehyde (I) with cyanacetic acid (II) by means of pyridine in toluene gives the 3-(4-hydroxyphenyl)propenenitrile (III), which by reaction first with methanolic HCl and then with methanolic ammonia is converted into the amidine (IV). Finally, this compound is condensed with 2-furylcarbonyl chloride (V) in pyridine and treated with methanesulfonic acid to afford the target sulfonate.

1 Niwas, S.; Moore, R.; Kilpatrick, J.M.; Babu, Y.S.; Johnson, H.; Kellogg, D.; Development of novel inhibitors of complement and coagulation serine proteases. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 088.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 12591 Cyanoacetic Acid; 2-Cyanoacetic acid 372-09-8 C3H3NO2 详情 详情
(III) 27819 (E)-3-(4-hydroxyphenyl)-2-propenenitrile C9H7NO 详情 详情
(IV) 27820 (E)-3-(4-hydroxyphenyl)-2-propenimidamide C9H10N2O 详情 详情
(V) 26093 2-Furoyl chloride 527-69-5 C5H3ClO2 详情 详情

合成路线21

该中间体在本合成路线中的序号:(VIII)

4-Bromophenol (I) was acetylated with Ac2O and Et3N, and the resulting 4-bromophenyl acetate (II) was rearranged to 5'-bromo-2'-hydroxyacetophenone (III) in the presence of AlCl3 at 120 C. Subsequent nitration of (III) produced the 3'-nitroacetophenone (IV). The catalytic hydrogenation of the nitro group of (IV), with simultaneous halogen hydrogenolysis, furnished 3'-amino-2'-hydroxyacetophe-none (V). Then, diazotization of the amine group of (V), followed by treatment with KI and Cu powder gave iodide (VI). Coupling of 4-phenyl-1-butanol (VII) with 4-hydroxybenzaldehyde (VIII) under Mitsunobu conditions provided 4-(4-phenylbutoxy)benzaldehyde (IX). Further Wittig reaction of (IX) with methylene triphenylphosphorane (X) gave the styrene (XI). This was condensed with the iodoacetophenone (VI) in the presence of Pd(OAc)2 to produce the stilbene derivative (XII). The benzopyranone (XIII) was prepared by condensation of hydroxyacetophenone (XII) with diethyl oxalate in the presence of NaOEt, followed by acid cyclization. After conversion of the ester function of (XIII) to the corresponding amide with methanolic ammonia, dehydration using POCl3 in DMF afforded nitrile (XIV). The required tetrazole ring was finally obtained by reaction with NaN3 and NH4Cl in DMF at 100 C.

1 Carganico, G.; Mauleon Casellas, D.; Pascual Avellana, J.; Garcia Perez, M.L.; Palomer Benet, A. (Menarini Industrie Farma Riunite srl); Benzopyran derivs. having leukotriene-antagonistic action. EP 0888327; ES 2127106; JP 2000506878; US 5990142; WO 9734885 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25313 4-bromophenol 106-41-2 C6H5BrO 详情 详情
(II) 27286 4-bromophenyl acetate C8H7BrO2 详情 详情
(III) 27287 1-(5-bromo-2-hydroxyphenyl)-1-ethanone 1450-75-5 C8H7BrO2 详情 详情
(IV) 27288 1-(5-bromo-2-hydroxy-3-nitrophenyl)-1-ethanone C8H6BrNO4 详情 详情
(V) 27289 1-(3-amino-2-hydroxyphenyl)-1-ethanone C8H9NO2 详情 详情
(VI) 27290 1-(2-hydroxy-3-iodophenyl)-1-ethanone C8H7IO2 详情 详情
(VII) 27291 4-phenyl-1-butanol 3360-41-6 C10H14O 详情 详情
(VIII) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(IX) 27292 4-(4-phenylbutoxy)benzaldehyde C17H18O2 详情 详情
(X) 27301 methylene(triphenyl)phosphorane C19H17P 详情 详情
(XI) 27293 1-(4-phenylbutoxy)-4-vinylbenzene C18H20O 详情 详情
(XII) 27294 1-(2-hydroxy-3-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]phenyl)-1-ethanone C26H26O3 详情 详情
(XIII) 27295 ethyl 4-oxo-8-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]-4H-chromene-2-carboxylate C30H28O5 详情 详情
(XIV) 27296 4-oxo-8-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]-4H-chromene-2-carbonitrile C28H23NO3 详情 详情

合成路线22

该中间体在本合成路线中的序号:(I)

Alkylation of p-hydroxybenzaldehyde (I) with 1-(2-chloroethyl)piperidine (II) afforded 4-(2-piperidinylethoxy)benzaldehyde (III). Aldehyde function reduction using NaBH4 provided the benzylic alcohol (IV). Alternatively, alcohol (IV) can be obtained by reaction of 4-hydroxybenzyl alcohol (A) with 1-(2-chloroethyl)piperidine hydrochloride (II) by means of NaOH and benzyl triethylammonium bromide in toluene.The hydrochloride salt of (IV) was then treated with SOCl2 to furnish chloride (V).

1 Silvestre, J.S.; Sorbera, L.A.; Castaner, J.; Pipendoxifene. Drugs Fut 2002, 27, 10, 942.
2 Vid, G.; Potoski, J.R.; Raveendranath, P.; Zeldis, J.; Ren, J. (American Home Products Corp.); Novel aryloxy-alkyl-dialkylamines. EP 1025077; WO 9919293 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 29474 4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol 4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol 623-05-2 C7H8O2 详情 详情
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 10117 1-(2-Chloroethyl)piperidine; N-(2-Chloroethyl)piperidine 1932-03-2 C7H14ClN 详情 详情
(III) 35795 4-[2-(1-piperidinyl)ethoxy]benzaldehyde 26815-04-3 C14H19NO2 详情 详情
(IV) 35796 [4-[2-(1-piperidinyl)ethoxy]phenyl]methanol C14H21NO2 详情 详情
(V) 46522 1-[2-[4-(chloromethyl)phenoxy]ethyl]piperidine; 4-(chloromethyl)phenyl 2-(1-piperidinyl)ethyl ether C14H20ClNO 详情 详情

合成路线23

该中间体在本合成路线中的序号:(VI)

The known benzofuran carbinol (I) was converted to mesylate (II) upon treatment with methanesulfonyl chloride and triethylamine and then condensed with (S)-prolinol (III) at 120 C to afford adduct (IV). Subsequent chlorination of (IV) with concomitant rearrangement by means of thionyl chloride in benzene produced the 3-chloropiperidine derivative (V). The reaction of (V) with 4-hydroxybenzaldehyde (VI) in the presence of K2CO3 in DMF at 80 C furnished a mixture of six- and five-membered ring products (VII) and (VIII), which were separated by column chromatography. Condensation of the required aldehyde (VIII) with thiazolidinedione (IX) using piperidinium benzoate in refluxing toluene provided the target benzylidene thiazolidine, which was finally converted to the corresponding maleate salt.

1 Reddy, K.A.; Lohray, B.B.; Brushan, V.; et al.; Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones. J Med Chem 1999, 42, 11, 1927.
2 Ramanujam, R.; Chakrabarti, R.; Lohray, B.B.; Bajji, A.C.; Lohray, V.B.; Alla, S.R. (Dr. Reddy's Research Foundation); Heterocyclic cpds. having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compsns. containing them. US 5889032 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30773 [5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methanol C21H26O3 详情 详情
(II) 30774 [5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl methanesulfonate C22H28O5S 详情 详情
(III) 21347 (2S)pyrrolidinylmethanol 23356-96-9 C5H11NO 详情 详情
(IV) 30775 ((2S)-1-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]pyrrolidinyl)methanol C26H35NO3 详情 详情
(V) 30776 (3R)-1-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]-3-chloropiperidine; benzyl 3-[[(3R)-3-chloropiperidinyl]methyl]-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl ether C26H34ClNO2 详情 详情
(VI) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VII) 30777 4-[((3R)-1-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]piperidinyl)oxy]benzaldehyde C33H39NO4 详情 详情
(VIII) 30778 4-[((2S)-1-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]pyrrolidinyl)methoxy]benzaldehyde C33H39NO4 详情 详情
(IX) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情

合成路线24

该中间体在本合成路线中的序号:(I)

Alkylation of 4-hydroxybenzaldehyde (I) with 1-(2-chloroethyl)piperidine hydrochloride (II) in the presence of K2CO3 yielded (piperidinylethoxy)benzaldehyde (III), which was further reduced to the benzylic alcohol (IV) with methanolic NaBH4. Coupling of (IV) with thioacetic acid according to the Mitsunobu procedure yielded thioacetate ester (V), which was converted to the corresponding thiol (VI) by reductive cleavage of the thioester group with LiAlH4.

1 Leblanc, G.; Noël, P.; Poirier, D.; Labrie, F.; Breton, E.; Luu-The, V.; Tremblay, M.R.; Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: Chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities. Bioorg Med Chem 1999, 7, 6, 1013.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 10117 1-(2-Chloroethyl)piperidine; N-(2-Chloroethyl)piperidine 1932-03-2 C7H14ClN 详情 详情
(III) 35795 4-[2-(1-piperidinyl)ethoxy]benzaldehyde 26815-04-3 C14H19NO2 详情 详情
(IV) 35796 [4-[2-(1-piperidinyl)ethoxy]phenyl]methanol C14H21NO2 详情 详情
(V) 35797 S-[4-[2-(1-piperidinyl)ethoxy]benzyl] ethanethioate C16H23NO2S 详情 详情
(VI) 35798 4-[2-(1-piperidinyl)ethoxy]benzylhydrosulfide; [4-[2-(1-piperidinyl)ethoxy]phenyl]methanethiol C14H21NOS 详情 详情

合成路线25

该中间体在本合成路线中的序号:(I)

Alkylation of 4-hydroxybenzaldehyde (I) with iodoacetic acid in the presence of K2CO3 afforded ether (II). Subsequent condensation of (II) with 5,6-diamino-1,3-dipropyluracil (III) gave imine (IV). Oxidative ring closure by means of FeCl3 in boiling EtOH, with concomitant esterification, furnished xanthine (V). The ethyl ester of (V) was then displaced by hydrazine to yield hydrazide (VI). Finally, condensation of (VI) with dimethylmaleic anhydride (VII) gave rise to the corresponding maleimide.

1 Jacobson, K.A.; et al.; Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J Med Chem 1985, 28, 9, 1334-40.
2 Karton, Y.; Melman, N.; Ji, X.-D.; Jacobson, K.A.; Linden, J.; Kim, Y.-C.; Acyl-hydrazide derivatives of a xanthine carboxylic congener (XCC) as selective antagonists at human A2B adenosine receptors. Drug Dev Res 1999, 47, 4, 178.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
40086 2-iodoacetic acid 64-69-7 C2H3IO2 详情 详情
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 25513 2-(4-Formylphenoxy)acetic acid; 4-Formyl phenoxy acetic acid 22042-71-3 C9H8O4 详情 详情
(III) 14628 5,6-diamino-1,3-dipropyl-2,4(1H,3H)-pyrimidinedione C10H18N4O2 详情 详情
(IV) 35608 2-(4-[[(6-amino-2,4-dioxo-1,3-dipropyl-1,2,3,4-tetrahydro-5-pyrimidinyl)imino]methyl]phenoxy)acetic acid C19H24N4O5 详情 详情
(V) 35609 ethyl 2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetate C21H26N4O5 详情 详情
(VI) 35610 2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetohydrazide C19H24N6O4 详情 详情
(VII) 35611 3,4-dimethyl-2,5-furandione 766-39-2 C6H6O3 详情 详情

合成路线26

该中间体在本合成路线中的序号:(VI)

Mesylate (I) is heated with L-prolinol (II) to furnish pyrrolidine derivative (III), which can be converted into (VII) by different ways: 1) Treatment of (III) with t-BuOK and reaction with 4-fluorobenzaldehyde (IV) in DMF. 2) Conversion of (III) into chloropiperidine derivative (V) by means of SOCl2 in benzene, followed by reaction with 4-hydroxyaldehyde (VI) and K2CO3 in DMF in and chromatographic separation. 3) Mitsunobu reaction between (III) and 4-hydroxyaldehyde (VI) by treatment with PPh3 and DEAD in THF, followed by chromatographic separation. Derivative (VII) is condensed with 2,4-thiazolidinedione (VIII) in toluene in the presence of piperidine and benzoic acid to afford (IX), which is finally converted into its maleate form by treatment with maleic acid in Et2O.

1 Lohray, B.B.; Anji Reddy, K.; Bhushan, V.; et al.; Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives. J Med Chem 1999, 42, 17, 3265.
2 Alla, S.R.; Ramanujam, R.; Bajji, A.C.; Lohray, B.B.; Lohray, V.B.; Chakrabarti, R. (Dr. Reddy's Research Foundation; Reddy-Cheminor Inc.); Novel heterocyclic cpds. having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compsns. containing them. WO 9741121 .
3 Ramanujam, R.; Chakrabarti, R.; Lohray, B.B.; Bajji, A.C.; Lohray, V.B.; Alla, S.R. (Dr. Reddy's Research Foundation); Heterocyclic cpds. having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compsns. containing them. US 5889032 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 26454 6-(benzyloxy)-2,5,7,8-tetramethyl-2-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)chromane C24H32O3S 详情 详情
(II) 21347 (2S)pyrrolidinylmethanol 23356-96-9 C5H11NO 详情 详情
(III) 42275 ((2S)-1-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]pyrrolidinyl)methanol C26H35NO3 详情 详情
(IV) 12337 4-fluorobenzaldehyde 459-57-4 C7H5FO 详情 详情
(V) 42276 (3R)-1-[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]-3-chloropiperidine; benzyl 2-[(3R)-3-chloropiperidinyl]-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-6-yl ether C25H32ClNO2 详情 详情
(VI) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VII) 42277 4-[((2S)-1-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]pyrrolidinyl)methoxy]benzaldehyde C33H39NO4 详情 详情
(VIII) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情
(IX) 42278 5-((Z)-[4-[((2S)-1-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]pyrrolidinyl)methoxy]phenyl]methylidene)-1,3-thiazolidine-2,4-dione C36H40N2O5S 详情 详情

合成路线27

该中间体在本合成路线中的序号:(X)

Intermediate (VIII) can be obtained as follows: Bromination of glucuronate derivative (X) by means of TiBr4 in CH2Cl2 followed by reaction with p-hydroxybenzaldehyde (XI) in acetonitrile in the presence of Ag2O affords derivative (XII), whose aldehyde moiety is then reduced by means of NaBH4 and silica gel in isopropanol/CHCl3 to provide benzyl alcohol (XIII). Finally, O-acetyl groups of (XIII) are cleaved by means of NaOMe in MeOH to furnish intermediate (VIII).

1 Leu, Y.-L.; Roffler, S.R.; Chern, J.-W.; Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT). J Med Chem 1999, 42, 18, 3623.
2 Chern, J.-W.; Roffler, S.; Leu, Y.-L. (Academia Sinica); Proactive antitumor cpds.. EP 0990661; US 6043367 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 44150 methyl 3,4,5-trihydroxy-6-[4-(hydroxymethyl)phenoxy]tetrahydro-2H-pyran-2-carboxylate C14H18O8 详情 详情
(X) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(XI) 44154 methyl 3,4,5,6-tetrakis(acetoxy)tetrahydro-2H-pyran-2-carboxylate C15H20O11 详情 详情
(XII) 44152 methyl 3,4,5-tris(acetoxy)-6-(4-formylphenoxy)tetrahydro-2H-pyran-2-carboxylate C20H22O11 详情 详情
(XIII) 44153 methyl 3,4,5-tris(acetoxy)-6-[4-(hydroxymethyl)phenoxy]tetrahydro-2H-pyran-2-carboxylate C20H24O11 详情 详情

合成路线28

该中间体在本合成路线中的序号:(V)

Treatment of glucuronic acid gamma-lactone (I) with sodium methoxide in methanol affords methyl glucuronate (II), which is further acylated by acetic anhydride to form the tetraacetate ester (III). Bromination of (III) with TiBr4, followed by coupling of the resultant bromide (IV) with p hydroxybenzaldehyde (V) in the presence of Ag2O yields the peracetylated glucuronide (VI). Aldehyde (VI) reduction employing NaBH4 in the presence of silica gel leads to the benzyl alcohol (VII). The acetate ester groups of (VII) are then removed with sodium methoxide in methanol to furnish (VIII).

1 Leu, Y.-L.; Roffler, S.R.; Chern, J.-W.; Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT). J Med Chem 1999, 42, 18, 3623.
2 Chern, J.-W.; Roffler, S.; Leu, Y.-L. (Academia Sinica); Proactive antitumor cpds.. EP 0990661; US 6043367 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18369 (3S,3aR,6R,6aR)-3,5,6-trihydroxytetrahydrofuro[3,2-b]furan-2(3H)-one 32449-92-6 C6H8O6 详情 详情
(II) 62238 methyl (2S,3S,4S,5R)-3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-carboxylate C7H12O7 详情 详情
(III) 17324 methyl (2S,3R,4S,5R)-3,4,5,6-tetrakis(acetoxy)tetrahydro-2H-pyran-2-carboxylate 7355-18-2 C15H20O11 详情 详情
(IV) 17580 methyl (2S,3S,4S,5R,6R)-3,4,5-tris(acetoxy)-6-bromotetrahydro-2H-pyran-2-carboxylate C13H17BrO9 详情 详情
(V) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VI) 62239 methyl (2S,3R,4S,5R)-3,4,5-tris(acetyloxy)-6-(4-formylphenoxy)tetrahydro-2H-pyran-2-carboxylate C20H22O11 详情 详情
(VII) 62240 methyl (2S,3R,4S,5R)-3,4,5-tris(acetyloxy)-6-[4-(hydroxymethyl)phenoxy]tetrahydro-2H-pyran-2-carboxylate C20H24O11 详情 详情
(VIII) 62241 methyl (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[4-(hydroxymethyl)phenoxy]tetrahydro-2H-pyran-2-carboxylate C14H18O8 详情 详情

合成路线29

该中间体在本合成路线中的序号:(III)

Reduction of 3-(4-fluorobenzoyl)propionic acid (I) by means of AlCl3 in CH2Cl2 and borane/tert-butylamine complex yields alcohol (II), which is then converted into aldehyde (IV) by reaction with 4-hydroxybenzaldehyde (III) in presence of PPh3 in THF and diethyl azodicarboxylate. Treatment of (IV) with a solution of methyltriphenylphosphonium bromide in THF and a solution of n-BuLi in hexane affords styrene derivative (V), which couples with 2’-hydroxy-3’-iodoacetophenone (VI) in presence of Et3N and Pd(OAc)2 in CH3CN to provide (VII). Cyclization of (VII) by means of a first treatment with NaOEt in EtOH followed by reaction with diethyl oxalate in Et2O/EtOH yields benzopyrane derivative (VIII) which is then hydrolyzed with NaOH in THF/MeOH to give (IX). Carboxylic acid (IX) is first converted into carboxamide (X) by treatment with a saturated NH3 solution in MeOH and then into carbonitrile (XI) by means of POCl3 in DMF. Finally, treatment of (XI) with a solution of NaN3, NH4Cl and DMF leads to the formation of the desired product.

1 Carganico, G.; Mauleon Casellas, D.; Pascual Avellana, J.; Garcia Perez, M.L.; Palomer Benet, A. (Menarini Industrie Farma Riunite srl); Benzopyran derivs. having leukotriene-antagonistic action. EP 0888327; ES 2127106; JP 2000506878; US 5990142; WO 9734885 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 17571 Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate 95-92-1 C6H10O4 详情 详情
(A) 30484 Methyl(triphenyl)phosphonium bromide 1779-49-3 C19H18BrP 详情 详情
(I) 39863 4-(4-fluorophenyl)-4-oxobutyric acid 366-77-8 C10H9FO3 详情 详情
(II) 41474 4-(4-fluorophenyl)-1-butanol C10H13FO 详情 详情
(III) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(IV) 41475 4-[4-(4-fluorophenyl)butoxy]benzaldehyde C17H17FO2 详情 详情
(V) 41476 1-fluoro-4-[4-(4-vinylphenoxy)butyl]benzene; 4-(4-fluorophenyl)butyl 4-vinylphenyl ether C18H19FO 详情 详情
(VI) 27290 1-(2-hydroxy-3-iodophenyl)-1-ethanone C8H7IO2 详情 详情
(VII) 41477 1-[3-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-2-hydroxyphenyl]-1-ethanone C26H25FO3 详情 详情
(VIII) 41478 ethyl 8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carboxylate C30H27FO5 详情 详情
(IX) 41479 8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carboxylic acid C28H23FO5 详情 详情
(X) 41480 8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carboxamide C28H24FNO4 详情 详情
(XI) 41481 8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carbonitrile C28H22FNO3 详情 详情

合成路线30

该中间体在本合成路线中的序号:(I)

Alkylation of 4-hydroxybenzaldehyde (I) with iodoacetic acid afforded 4-formylphenoxyacetic acid (II). This was condensed with 5,6-diamino-1,3-dipropyluracil (III) to produce imine (IV), which was oxidatively cyclized to xanthine (V) in the presence of ferric chloride. After activation of (V) as the corresponding acid chloride (VI), coupling with 4-aminobenzonitrile (VII) furnished the title amide.

1 Jacobson, K.A.; et al.; Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J Med Chem 1985, 28, 9, 1334-40.
2 Ji, X.; Kim, Y.-C.; Linden, J.; Jacobson, K.A.; Melman, N.; Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors. J Med Chem 2000, 43, 6, 1165.
3 Kim, Y.-C.; Linden, J.M.; Jocobson, K.A. (University of Virginia); Substd. 8-phenylxanthines useful as antagonists of A2B adenosine receptors. WO 0073307 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
40086 2-iodoacetic acid 64-69-7 C2H3IO2 详情 详情
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 25513 2-(4-Formylphenoxy)acetic acid; 4-Formyl phenoxy acetic acid 22042-71-3 C9H8O4 详情 详情
(III) 14628 5,6-diamino-1,3-dipropyl-2,4(1H,3H)-pyrimidinedione C10H18N4O2 详情 详情
(IV) 35608 2-(4-[[(6-amino-2,4-dioxo-1,3-dipropyl-1,2,3,4-tetrahydro-5-pyrimidinyl)imino]methyl]phenoxy)acetic acid C19H24N4O5 详情 详情
(V) 44758 2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetic acid C19H22N4O5 详情 详情
(VI) 44759 2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetyl chloride C19H21ClN4O4 详情 详情
(VII) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情

合成路线31

该中间体在本合成路线中的序号:(I)

The title compound was synthesized by two related methods. Stobbe condensation between 4-hydroxybenzaldehyde (I) and diethyl succinate (II) in the presence of NaOEt afforded the benzylidenesuccinate monoester (III). Coupling of (III) with cis-hexahydroisoindoline (IV) gave the amidoester (V). The phenolic hydroxyl group of (V) was then alkylated with tosylate (VI) to provide the corresponding ether (IX). Alternatively, intermediate (IX) was obtained by initial alkylation of 4-hydroxybenzaldehyde (I) with tosylate (VI). The resultant alkyloxy benzaldehyde (VII) was then subjected to Stobbe condensation with diethyl succinate (II) to afford the benzylidenesuccinate (VIII), which was further coupled with the bicyclic amine (IV) to produce (IX). Finally, ester (IX) obtained by either synthetic method was hydrolyzed with NaOH to furnish the target carboxylic acid.

1 Kitajima, H.; et al.; Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 37.
2 Kitajima, H.; et al.; Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer. Bioorg Med Chem Lett 2000, 10, 21, 2453.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 12313 diethyl succinate 123-25-1 C8H14O4 详情 详情
(III) 51544 (E)-3-(ethoxycarbonyl)-4-(4-hydroxyphenyl)-3-butenoic acid C13H14O5 详情 详情
(IV) 41059 (3aR,7aS)octahydro-1H-isoindole C8H15N 详情 详情
(V) 51545 ethyl (E)-2-[2-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-oxoethyl]-3-(4-hydroxyphenyl)-2-propenoate C21H27NO4 详情 详情
(VI) 51546 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl 4-methylbenzenesulfonate C19H19NO4S 详情 详情
(VII) 51547 ethyl (E)-2-[2-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-oxoethyl]-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-propenoate C33H38N2O5 详情 详情
(VIII) 19732 tert-butyl (1S,2R)-1-benzyl-3-[(2S,4R)-2-[(tert-butylamino)carbonyl]-4-(4-pyridinylmethoxy)piperidinyl]-2-hydroxypropylcarbamate C31H46N4O5 详情 详情
(IX) 51548 (E)-3-(ethoxycarbonyl)-4-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-3-butenoic acid C25H25NO6 详情 详情

合成路线32

该中间体在本合成路线中的序号:(VI)

Acetylation of aniline (I) with acetic anhydride (Ac2O) in HOAc followed by reaction with mercurium acetate (Hg(OAc)2) and HClO4 in HOAc provides derivative (II), which is first subjected to dimerization by treatment with Cu and PdCl2 in pyridine and then nitrated by means of HNO3 in HOAc to afford substituted biphenyl (III). Hydrolysis of (III) with H2SO4 gives 4,4'-diamino-3,3'-dinitrobiphenyl (IV), which is converted into tetraaminobiphenyl (V) by hydrogenation over Raney-Ni in acetone. Mitsunobu reaction between p-hydroxybenzaldehyde (VI) and 3-dimethylamino propan-1-ol (VII) with PPh3 and DEAD in THF gives substituted benzaldehyde (VIII), which is finally cyclized with biphenyl derivative (V) by heating in nitrobenzene to furnish the target product.

1 Neidle, S.; et al.; Symmetric bis-benzimidazoles: New sequence-selective DNA-binding molecules. Chem Commun (London) 1999, 10, 929.
2 Kelland, L.R.; Opoku-Boahen, Y.; Mann, J.; Baron, A.; johansson, E.; Parkinson, G.; Neidle, S.; A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity. J Med Chem 2001, 44, 2, 138.
3 Mann, J.; Neidle, S. (Institute of Cancer Research; Queen's University of Belfast; University of Reading); Bis-benzazoles and their use as antineoplastic agents. WO 0063180 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12294 Aniline; Phenylamine 62-53-3 C6H7N 详情 详情
(II) 47202   C10H11HgNO3 详情 详情
(III) 47203 N-[4'-(acetamido)-3,3'-dinitro[1,1'-biphenyl]-4-yl]acetamide C16H14N4O6 详情 详情
(IV) 47204 3,3'-dinitro[1,1'-biphenyl]-4,4'-diamine; 4'-amino-3,3'-dinitro[1,1'-biphenyl]-4-ylamine 6271-79-0 C12H10N4O4 详情 详情
(V) 47205 3',4,4'-triamino[1,1'-biphenyl]-3-ylamine; [1,1'-biphenyl]-3,3',4,4'-tetramine 91-95-2 C12H14N4 详情 详情
(VI) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VII) 37173 3-(dimethylamino)-1-propanol 3179-63-3 C5H13NO 详情 详情
(VIII) 47206 4-[3-(dimethylamino)propoxy]benzaldehyde C12H17NO2 详情 详情

合成路线33

该中间体在本合成路线中的序号:(I)

Treatment of 4-hydroxybenzaldehyde (I) with O-ethylhydroxylamine produced the corresponding O-ethyloxime (II). Coupling of (II) with alcohol (III) under Mitsunobu conditions then gave the title ether.

1 Wu, W.-Y.; Watson, K.; Jin, B.; Krippner, G.; McConnell, D. (Biota Scientific Management Pty Ltd.); Antiviral agents. WO 0078746 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 49088 4-hydroxybenzaldehyde O-ethyloxime C9H11NO2 详情 详情
(III) 49089 2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]-1-ethanol C12H19N3O 详情 详情

合成路线34

该中间体在本合成路线中的序号:(VII)

The condensation of 2,4,6-trihydroxyacetophenone (IV) with tetraacetylbromoglucose (V) by means of NaOH in acetone-water gives tetraacetylphloracetophenone-4-O-glucoside (VI), which is condensed with 4-hydroxybenzaldehyde (VII), by means of KOH in alcohol yielding the chalcone derivative (VIII). Finally, this compound is cyclized and deprotected by a treatment with refluxing aqueous HCl.

1 Zemplen, G.; Bognar, R.; Synthese eines phloracetophenon-glucosids, eines naringenin-glucosids und des p-phlorhizins. Ber 1942, 75, 645-655.
2 Castaner, J.; Serradell, M.N.; Aboul-Enein, H.Y.; Naringenin. Drugs Fut 1984, 9, 9, 653-654.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 34293 1-(2,4,6-trihydroxyphenyl)-1-ethanone 480-66-0 C8H8O4 详情 详情
(V) 27260 (2R,3R,4S,5S,6R)-4,5-bis(acetoxy)-6-[(acetoxy)methyl]-2-bromotetrahydro-2H-pyran-3-yl acetate 572-09-8 C14H19BrO9 详情 详情
(VI) 34294 (2R,3R,4S,5R)-6-(4-acetyl-3,5-dihydroxyphenoxy)-4,5-bis(acetoxy)-2-[(acetoxy)methyl]tetrahydro-2H-pyran-3-yl acetate C22H26O13 详情 详情
(VII) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VIII) 34295 (E)-1-(2,6-dihydroxy-4-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]phenyl)-3-(4-hydroxyphenyl)-2-propen-1-one C21H22O10 详情 详情

合成路线35

该中间体在本合成路线中的序号:(VII)

The intermediate aldehyde (IX) was synthesized by alkylation of the sodium salt of 4-hydroxybenzaldehyde (VII) with methyl 8-bromooctanoate (VIII).

1 Folkes, A.; et al.; Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1. Bioorg Med Chem Lett 2001, 11, 19, 2589.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(VIII) 53130 methyl 8-bromooctanoate 26825-92-3 C9H17BrO2 详情 详情
(IX) 53131 methyl 8-(4-formylphenoxy)octanoate n/a C16H22O4 详情 详情

合成路线36

该中间体在本合成路线中的序号:(I)

4-Hydroxybenzaldehyde (I) was acetylated using Ac2O in pyridine. The resultant 4-(acetyloxy)benzaldehyde (II) was then subjected to a Wadsworth-Emmons condensation with trimethyl phosphonoacetate to afford methyl 4-(acetyloxy)cinnamate (III). After catalytic double bond hydrogenation, the resultant saturated ester (IV) was reduced by LiAlH4 to furnish 3-(4-hydroxyphenyl)-1-propanol (V) –alternatively (V) can be obtained by reduction with LiAlH4 of the propionic acid derivative (VI) (isolated from Asplenium onopteris)-. Methylation of the phenolic hydroxyl group of (V) with iodomethane and K2CO3 in acetone gave the methyl ether (VII). Then, oxidation of alcohol (VII) to 3-(4-methoxyphenyl)propanal (VIII) was accomplished by means of pyridinium chlorochromate.

1 Gonzalez, A.G.; et al.; Synthesis and antiproliferative activity of a new compound containing an alpha-methylene-gamma-lactone group. J Med Chem 2002, 45, 12, 2358.
2 Bermejo Barrera, J.; Hernandez Silva, M.; Alvarez de Mon, M.; Pivel Ranieri, J.P. (CSIC (Consejo Superior de Investigaciones Cientificas)); Derivs. of p-hydroxy phenyl propionic acid as antiproliferative agents. ES 2160093; WO 0172733 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 56432 4-Acetoxybenzaldehyde; p-Acetoxybenzaldehyde; p-Formylphenyl acetate 878-00-2 C9H8O3 详情 详情
(III) 56433 methyl (E)-3-[4-(acetyloxy)phenyl]-2-propenoate C12H12O4 详情 详情
(IV) 56434 methyl 3-[4-(acetyloxy)phenyl]propanoate C12H14O4 详情 详情
(V) 56435 3-(4-Hydroxyphenyl)-1-propanol C9H12O2 详情 详情
(VI) 25691 3-(4-hydroxyphenyl)propionic acid 501-97-3 C9H10O3 详情 详情
(VII) 56436 3-(p-Methoxyphenyl)propanol; 3-(4-Methoxyphenyl)propanol 5406-18-8 C10H14O2 详情 详情
(VIII) 56437 3-(4-methoxyphenyl)propanal C10H12O2 详情 详情

合成路线37

该中间体在本合成路线中的序号:(I)

Knoevenagel condensation of 4-hydroxybenzaldehyde (I) with dimethyl malonate in the presence of pyridinium acetate affords the benzylidene malonate (II), which is further hydrogenated over Pd/C to furnish dimethyl (4-hydroxybenzyl)malonate (III). Then, Mitsunobu coupling between phenol (III) and 4-chlorophenethyl alcohol (IV) gives rise to the title compound.

1 Catini, R.; Brunetti, T.; Arduini, A.; et al.; New phenylalkylcarboxylate derivatives as hypoglycemic and hypolipidemic agents. Drugs Fut 2002, 27, Suppl. A.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 58897 2-[(4-Hydroxyphenyl)methylene] propanedioic acid dimethyl ester; 4-Hydroxy benzylidene malonic acid dimethyl ester; Dimethyl 2-[(4-hydroxyphenyl)methylene]propane dioate 51947-45-6 C12H12O5 详情 详情
(III) 58898 dimethyl 2-(4-hydroxybenzyl)malonate C12H14O5 详情 详情
(IV) 33783 2-(4-chlorophenyl)-1-ethanol 1875-88-3 C8H9ClO 详情 详情

合成路线38

该中间体在本合成路线中的序号:(III)

 

1 Adiyrunan M, Guner D, Yurdakul A, et al. 2003. Ap rocess for the production of 5-[4-[2-(5-ethyl-2-pyridylethoxy) benzyl]-2,4-thiazolidinedione hydrochloride. W0 2004000810
2 Edward HJ. 1993. A reduction method for substituted 5-methylene-thiazoliclinediones. W0 9313095
3 Ulliard M, Derrien Y, Pintus T. 2002. Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin. W0 200206457
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14139 2-(5-Ethyl-2-pyridinyl)-1-ethanol 5223-06-3 C9H13NO 详情 详情
(II) 62866 2-(5-ethyl-2-pyridinyl)ethyl methanesulfonate C10H15NO3S 详情 详情
(III) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(IV) 14141 4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzaldehyde C16H17NO2 详情 详情
(V) 10883 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione 2295-31-0 C3H3NO2S 详情 详情
(VI) 14143 5-((E)-[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methylidene)-1,3-thiazolane-2,4-dione 144809-28-9 C19H18N2O3S 详情 详情
Extended Information